Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis

Thelen M, Damme M, Schweizer M, Hagel C, Wong A, Cooper JD, Braulke T, Galliciotti G (2012)
PLOS ONE 7(4).

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ;
Abstract
Variant late-infantile neuronal ceroid lipofuscinosis, a fatal lysosomal storage disorder accompanied by regional atrophy and pronounced neuron loss in the brain, is caused by mutations in the CLN6 gene. CLN6 is a non-glycosylated endoplasmic reticulum (ER)-resident membrane protein of unknown function. To investigate mechanisms contributing to neurodegeneration in CLN6 disease we examined the nclf mouse, a naturally occurring model of the human CLN6 disease. Prominent autofluorescent and electron-dense lysosomal storage material was found in cerebellar Purkinje cells, thalamus, hippocampus, olfactory bulb and in cortical layer II to V. Another prominent early feature of nclf pathogenesis was the localized astrocytosis that was evident in many brain regions and the more widespread microgliosis. Expression analysis of mutant Cln6 found in nclf mice demonstrated synthesis of a truncated protein with a reduced half-life. Whereas the rapid degradation of the mutant Cln6 protein can be inhibited by proteasomal inhibitors, there was no evidence for ER stress or activation of the unfolded protein response in various brain areas during postnatal development. Age-dependent increases in LC3-II, ubiquitinated proteins, and neuronal p62-positive aggregates were observed, indicating a disruption of the autophagy-lysosome degradation pathway of proteins in brains of nclf mice, most likely due to defective fusion between autophagosomes and lysosomes. These data suggest that proteasomal degradation of mutant Cln6 is sufficient to prevent the accumulation of misfolded Cln6 protein, whereas lysosomal dysfunction impairs constitutive autophagy promoting neurodegeneration.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Thelen M, Damme M, Schweizer M, et al. Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. PLOS ONE. 2012;7(4).
Thelen, M., Damme, M., Schweizer, M., Hagel, C., Wong, A., Cooper, J. D., Braulke, T., et al. (2012). Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. PLOS ONE, 7(4).
Thelen, M., Damme, M., Schweizer, M., Hagel, C., Wong, A., Cooper, J. D., Braulke, T., and Galliciotti, G. (2012). Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. PLOS ONE 7.
Thelen, M., et al., 2012. Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. PLOS ONE, 7(4).
M. Thelen, et al., “Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis”, PLOS ONE, vol. 7, 2012.
Thelen, M., Damme, M., Schweizer, M., Hagel, C., Wong, A., Cooper, J.D., Braulke, T., Galliciotti, G.: Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis. PLOS ONE. 7, (2012).
Thelen, Melanie, Damme, Markus, Schweizer, Michaela, Hagel, Christian, Wong, Andrew, Cooper, Jonathan D., Braulke, Thomas, and Galliciotti, Giovanna. “Disruption of the Autophagy-Lysosome Pathway is Involved in Neuropathology of the nclf Mouse Model of Neuronal Ceroid Lipofuscinosis”. PLOS ONE 7.4 (2012).
This data publication is cited in the following publications:
This publication cites the following data publications:

18 Citations in Europe PMC

Data provided by Europe PubMed Central.

Autophagy in the physiology and pathology of the central nervous system.
Nikoletopoulou V, Papandreou ME, Tavernarakis N., Cell Death Differ. 22(3), 2015
PMID: 25526091
Autophagy in neuronal cells: general principles and physiological and pathological functions.
Damme M, Suntio T, Saftig P, Eskelinen EL., Acta Neuropathol. 129(3), 2015
PMID: 25367385
Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae.
Emanuel R, Sergin I, Bhattacharya S, Turner JN, Epelman S, Settembre C, Diwan A, Ballabio A, Razani B., Arterioscler. Thromb. Vasc. Biol. 34(9), 2014
PMID: 25060788
X-ray fluorescence imaging reveals subcellular biometal disturbances in a childhood neurodegenerative disorder.
Grubman A, James SA, James J, Duncan C, Volitakis I, Hickey JL, Crouch PJ, Donnelly PS, Kanninen KM, Liddell JR, Cotman SL, de Jonge , White AR., Chem Sci 5(6), 2014
PMID: 24976945
Lithium and autophagy.
Motoi Y, Shimada K, Ishiguro K, Hattori N., ACS Chem Neurosci 5(6), 2014
PMID: 24738557
Deregulation of subcellular biometal homeostasis through loss of the metal transporter, Zip7, in a childhood neurodegenerative disorder.
Grubman A, Lidgerwood GE, Duncan C, Bica L, Tan JL, Parker SJ, Caragounis A, Meyerowitz J, Volitakis I, Moujalled D, Liddell JR, Hickey JL, Horne M, Longmuir S, Koistinaho J, Donnelly PS, Crouch PJ, Tammen I, White AR, Kanninen KM., Acta Neuropathol Commun 2(), 2014
PMID: 24581221
Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease.
Damme M, Brandenstein L, Fehr S, Jankowiak W, Bartsch U, Schweizer M, Hermans-Borgmeyer I, Storch S., Neurobiol. Dis. 65(), 2014
PMID: 24423645
A murine model of variant late infantile ceroid lipofuscinosis recapitulates behavioral and pathological phenotypes of human disease.
Morgan JP, Magee H, Wong A, Nelson T, Koch B, Cooper JD, Weimer JM., PLoS ONE 8(11), 2013
PMID: 24223841
Progressive retinal degeneration and glial activation in the CLN6 (nclf) mouse model of neuronal ceroid lipofuscinosis: a beneficial effect of DHA and curcumin supplementation.
Mirza M, Volz C, Karlstetter M, Langiu M, Somogyi A, Ruonala MO, Tamm ER, Jagle H, Langmann T., PLoS ONE 8(10), 2013
PMID: 24124525
Lysosomal membrane permeability stimulates protein aggregate formation in neurons of a lysosomal disease.
Micsenyi MC, Sikora J, Stephney G, Dobrenis K, Walkley SU., J. Neurosci. 33(26), 2013
PMID: 23804102
Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis.
Kanninen KM, Grubman A, Caragounis A, Duncan C, Parker SJ, Lidgerwood GE, Volitakis I, Ganio G, Crouch PJ, White AR., Biol Open 2(6), 2013
PMID: 23789114
NCL disease mechanisms.
Palmer DN, Barry LA, Tyynela J, Cooper JD., Biochim. Biophys. Acta 1832(11), 2013
PMID: 23707513
Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of ClC-5.
D'Antonio C, Molinski S, Ahmadi S, Huan LJ, Wellhauser L, Bear CE., Biochem. J. 452(3), 2013
PMID: 23566014
Use of model organisms for the study of neuronal ceroid lipofuscinosis.
Bond M, Holthaus SM, Tammen I, Tear G, Russell C., Biochim. Biophys. Acta 1832(11), 2013
PMID: 23338040
A novel interaction between aging and ER overload in a protein conformational dementia.
Schipanski A, Lange S, Segref A, Gutschmidt A, Lomas DA, Miranda E, Schweizer M, Hoppe T, Glatzel M., Genetics 193(3), 2013
PMID: 23335331
The endolysosomal system in cell death and survival.
Repnik U, Cesen MH, Turk B., Cold Spring Harb Perspect Biol 5(1), 2013
PMID: 23284043
Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis.
Passantino R, Cascio C, Deidda I, Galizzi G, Russo D, Spedale G, Guarneri P., Biochim. Biophys. Acta 1833(3), 2013
PMID: 23142642

50 References

Data provided by Europe PubMed Central.

Loss of autophagy in the central nervous system causes neurodegeneration in mice.
Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E, Tanaka K., Nature 441(7095), 2006
PMID: 16625205
Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice.
Hara T, Nakamura K, Matsui M, Yamamoto A, Nakahara Y, Suzuki-Migishima R, Yokoyama M, Mishima K, Saito I, Okano H, Mizushima N., Nature 441(7095), 2006
PMID: 16625204
Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease).
Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, Saftig P, Uchiyama Y., Am. J. Pathol. 167(6), 2005
PMID: 16314482
Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.
Cao Y, Espinola JA, Fossale E, Massey AC, Cuervo AM, MacDonald ME, Cotman SL., J. Biol. Chem. 281(29), 2006
PMID: 16714284
Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis.
Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD., Neurobiol. Dis. 25(1), 2007
PMID: 17046272
p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy.
Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T., J. Biol. Chem. 282(33), 2007
PMID: 17580304
ER chaperones in mammalian development and human diseases.
Ni M, Lee AS., FEBS Lett. 581(19), 2007
PMID: 17481612
No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease.
Farfel-Becker T, Vitner E, Dekel H, Leshem N, Enquist IB, Karlsson S, Futerman AH., Hum. Mol. Genet. 18(8), 2009
PMID: 19193629
Dissecting the ER-associated degradation of a misfolded polytopic membrane protein.
Nakatsukasa K, Huyer G, Michaelis S, Brodsky JL., Cell 132(1), 2008
PMID: 18191224
Autophagy in the pathogenesis of disease.
Levine B, Kroemer G., Cell 132(1), 2008
PMID: 18191218
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T., EMBO J. 19(21), 2000
PMID: 11060023
A block of autophagy in lysosomal storage disorders.
Settembre C, Fraldi A, Jahreiss L, Spampanato C, Venturi C, Medina D, de Pablo R, Tacchetti C, Rubinsztein DC, Ballabio A., Hum. Mol. Genet. 17(1), 2008
PMID: 17913701
Autophagy, mitochondria and cell death in lysosomal storage diseases.
Kiselyov K, Jennigs JJ Jr, Rbaibi Y, Chu CT., Autophagy 3(3), 2007
PMID: 17329960
Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection.
Nedelsky NB, Todd PK, Taylor JP., Biochim. Biophys. Acta 1782(12), 2008
PMID: 18930136
Alpha-Synuclein is degraded by both autophagy and the proteasome.
Webb JL, Ravikumar B, Atkins J, Skepper JN, Rubinsztein DC., J. Biol. Chem. 278(27), 2003
PMID: 12719433
Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity.
Kamimoto T, Shoji S, Hidvegi T, Mizushima N, Umebayashi K, Perlmutter DH, Yoshimori T., J. Biol. Chem. 281(7), 2006
PMID: 16365039
Late onset neurodegeneration in the Cln3-/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation.
Pontikis CC, Cella CV, Parihar N, Lim MJ, Chakrabarti S, Mitchison HM, Mobley WC, Rezaie P, Pearce DA, Cooper JD., Brain Res. 1023(2), 2004
PMID: 15374749
Thalamocortical neuron loss and localized astrocytosis in the Cln3Deltaex7/8 knock-in mouse model of Batten disease.
Pontikis CC, Cotman SL, MacDonald ME, Cooper JD., Neurobiol. Dis. 20(3), 2005
PMID: 16006136
The neuronal ceroid lipofuscinoses: the same, but different?
Cooper JD., Biochem. Soc. Trans. 38(6), 2010
PMID: 21118105
Human lysosomal acid phosphatase is transported as a transmembrane protein to lysosomes in transfected baby hamster kidney cells.
Waheed A, Gottschalk S, Hille A, Krentler C, Pohlmann R, Braulke T, Hauser H, Geuze H, von Figura K., EMBO J. 7(8), 1988
PMID: 3056714
Topology and endoplasmic reticulum retention signals of the lysosomal storage disease-related membrane protein CLN6.
Heine C, Quitsch A, Storch S, Martin Y, Lonka L, Lehesjoki AE, Mole SE, Braulke T., Mol. Membr. Biol. 24(1), 2007
PMID: 17453415
Monitoring autophagy by electron microscopy in Mammalian cells.
Yla-Anttila P, Vihinen H, Jokitalo E, Eskelinen EL., Meth. Enzymol. 452(), 2009
PMID: 19200881
Cerebellar alterations and gait defects as therapeutic outcome measures for enzyme replacement therapy in α-mannosidosis.
Damme M, Stroobants S, Walkley SU, Lullmann-Rauch R, D'Hooge R, Fogh J, Saftig P, Lubke T, Blanz J., J. Neuropathol. Exp. Neurol. 70(1), 2011
PMID: 21157375

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 22536393
PubMed | Europe PMC

Search this title in

Google Scholar